Go Pro
NYSE:CLB

Core Laboratories (CLB) Stock Price, News & Analysis

Core Laboratories logo
$10.88 -0.38 (-3.33%)
As of 12:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Core Laboratories Stock (NYSE:CLB)

Advanced

Key Stats

Today's Range
$10.85
$11.25
50-Day Range
$9.87
$12.67
52-Week Range
$9.79
$20.36
Volume
218,535 shs
Average Volume
574,155 shs
Market Capitalization
$498.95 million
P/E Ratio
19.42
Dividend Yield
0.37%
Price Target
$21.00
Consensus Rating
Moderate Buy

Company Overview

Core Laboratories N.V. (NYSE: CLB) is a global provider of reservoir description and production enhancement services for the oil and natural gas industry. The company helps exploration and production companies evaluate subsurface formations, characterize reservoirs and improve the recovery of hydrocarbons from existing fields.

Core Laboratories’ reservoir description activities include laboratory analysis of rock and fluid samples, core analysis, special core analysis, fluid and pressure-volume-temperature studies, geochemical services and related geological and petrophysical evaluations. These services support decisions involving reservoir modeling, field development, completion design and enhanced oil recovery.

Through its production enhancement business, the company provides services and technologies used to improve well completions and production performance. Its offerings include well and completion diagnostics, stimulation-related services, production optimization and technologies designed to address challenges in mature and unconventional reservoirs.

Founded in 1936, Core Laboratories serves customers in major oil- and gas-producing regions around the world through an international network of laboratories, service facilities and technical personnel. Its customers include national oil companies, independent exploration and production companies and integrated energy producers.

AI Generated. May Contain Errors.

Core Laboratories Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

CLB MarketRank™: 

Core Laboratories scored higher than 95% of companies evaluated by MarketBeat, and ranked 19th out of 252 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Core Laboratories has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

  • Upside Potential

    Core Laboratories has a consensus price target of $21.00, representing about 87.0% upside from its current price of $11.23.

  • Amount of Analyst Coverage

    Core Laboratories has only been the subject of 2 research reports in the past 90 days.

  • Read more about Core Laboratories' stock forecast and price target.
  • Earnings Growth

    Earnings for Core Laboratories are expected to grow by 41.07% in the coming year, from $0.56 to $0.79 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Core Laboratories is 20.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.95.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Core Laboratories is 20.05, which means that it is trading at a less expensive P/E ratio than the Energy sector average P/E ratio of about 21.10.

  • Price to Earnings Growth Ratio

    Core Laboratories has a PEG Ratio of 2.24. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Core Laboratories has a P/B Ratio of 1.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Core Laboratories' valuation and earnings.
  • Percentage of Shares Shorted

    9.04% of the float of Core Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Core Laboratories has a short interest ratio ("days to cover") of 9.59.
  • Change versus previous month

    Short interest in Core Laboratories has recently decreased by 3.76%, indicating that investor sentiment is improving.
  • Dividend Yield

    Core Laboratories has a dividend yield of 0.36%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Core Laboratories does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Core Laboratories is 7.14%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 5.06% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.

  • Read more about Core Laboratories' dividend.
  • News Sentiment

    Core Laboratories has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Energy companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Core Laboratories this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for CLB on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $53,900.00 in company stock, which represents 0.0105% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Core Laboratories insiders have bought more of their company's stock than they have sold. Specifically, they have bought $53,900.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    1.26% of the stock of Core Laboratories is held by insiders.

  • Percentage Held by Institutions

    97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Core Laboratories' insider trading history.
Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLB Stock News Headlines

Zacks Research Issues Pessimistic Forecast for CLB Earnings
Top 3 Energy Stocks You'll Regret Missing In September
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel
Zacks Research Issues Pessimistic Estimate for CLB Earnings
Core Laboratories (CLB) Q2 2026 Earnings
See More Headlines

CLB Stock Analysis - Frequently Asked Questions

Core Laboratories' stock was trading at $16.02 at the beginning of the year. Since then, CLB stock has decreased by 29.9% and is now trading at $11.23.

Core Laboratories Inc. (NYSE:CLB) announced its quarterly earnings results on Wednesday, July, 29th. The oil and gas company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.02. Core Laboratories's revenue was down 4.3% compared to the same quarter last year.
Read the conference call transcript
.

Core Laboratories' top institutional shareholders include BlackRock Inc. (16.26%), Heartland Advisors Inc. (2.31%), Bank of New York Mellon Corp (0.87%) and Van ECK Associates Corp (0.86%).
View institutional ownership trends
.

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
7/29/2026
Record date for 8/31 Dividend
8/10/2026
Ex-Dividend for 8/31 Dividend
8/10/2026
Dividend Payable
8/31/2026
Today
9/21/2026
Next Earnings (Estimated)
10/28/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Energy
Industry
Energy Equipment & Services
Sub-Industry
Oil & Gas Equipment & Services
Current Symbol
NYSE:CLB
CIK
1958086
Fax
N/A
Employees
3,300
Year Founded
1936

Price Target and Rating

High Price Target
$21.00
Low Price Target
$21.00
Potential Upside/Downside
+93.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.56
Trailing P/E Ratio
19.42
Forward P/E Ratio
19.42
P/E Growth
2.24
Net Income
$29.67 million
Net Margins
5.10%
Pretax Margin
7.09%
Return on Equity
10.03%
Return on Assets
4.71%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
2.12
Quick Ratio
1.55

Sales & Book Value

Annual Sales
$526.52 million
Price / Sales
0.95
Cash Flow
$1.03 per share
Price / Cash Flow
10.53
Book Value
$5.85 per share
Price / Book
1.86

Miscellaneous

Outstanding Shares
45,880,000
Free Float
45,307,000
Market Cap
$498.95 million
Optionable
Optionable
Beta
1.08

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NYSE:CLB) was last updated on 9/21/2026 by MarketBeat.com Staff.
From Our Partners